DAVID PENDARVIS - 30 Jun 2023 Form 4 Insider Report for RESMED INC (RMD)

Role
Chief Administrative Officer
Signature
David Pendarvis, Chief Administrative Officer
Issuer symbol
RMD
Transactions as of
30 Jun 2023
Net transactions value
$0
Form type
4
Filing time
30 Jun 2023, 12:28:28 UTC
Previous filing
07 Jun 2023
Next filing
13 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding RMD ResMed Common Stock 89,729 30 Jun 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

DAVID PENDARVIS is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Remarks:

Reporting Person no longer an executive officer effective June 30, 2023.